1,4-DPCA
Prolyl hydroxylase inhibitor / Potent inhibitor of prolyl 4-hydroxylase (IC50=2-4 μM)1. Inhibits collagen deposition via inhibition of collagen proline hydroxylation2,3. Subcutaneous injection of a 1,4-DPCA containing hydrogel into Swiss Webster mice that do not show a regenerative phenotype increased expression of HIF1α over 5 days. Multiple injections led to regenerative wound healing after ear hole punch injury4.
Biochemicals & reagents
331830-20-7
1) Franklin et al. (2001), Inhibition of prolyl 4-hydroxylase in vitro and in vivo by members of a novel series of phenanthrolinones; Biochem. J., 353 333 2) Xiong et al. (2014), Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition; BMC Cancer, 14 1 3) Love and Jones et al. (2013), Transient inhibition of connective tissue infiltration and collagen deposition into porous poly(lactic-co-glycolic acid) discs; J. Biomed. Mater. Res., 101 3599 4) Zhang et al. (2015), Drug induced regeneration in adult mice; Sci. Transl. Med., 7 290ra92
RT
TARGET: Prolyl hydroxylase -- PATHWAY: Posttranslational modification -- RESEARCH AREA: Oxidative stress; Wound healing; Stem cells